Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: Involvement of IL-10 and IL-4

Cellular Microbiology

Volumn 10, Issue 3, 2008, Pages 713-728

  Qin, Di ^a   Zeng, Yi ^a   Qian, Chao ^a   Huang, Zan ^b   Lv, Zhigang ^a   Cheng, Lin ^a   Yao, Shuihong ^a   Tang, Qiao ^a   Chen, Xiuying ^a   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; LUCIFERASE; MESSENGER RNA; SMALL INTERFERING RNA; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; GENE TARGETING; GENETIC TRANSCRIPTION; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; LYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; RISK FACTOR; RNA INTERFERENCE; VIRUS REPLICATION;

ANIMALS; CELL LINE; GENE SILENCING; HERPESVIRUS 1, HUMAN; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-10; INTERLEUKIN-4; RNA, VIRAL; VIRAL PROTEINS; VIRUS REPLICATION;

HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 38849116900     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/j.1462-5822.2007.01079.x     Document Type: Article

References (53)

1. Benjamin, D., Knobloch, T.J., and Dayton, M.A. (1992) Human B-cell interleukin-10: B-cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80: 1289-1298.
2. van Benthem, B.H., Spaargaren, J., van Den Hoek, J.A., Merks, J., Coutinho, R.A., and Prins, M. (2001) Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 77: 120-124.
3. Beral, V., and Newton, R. (1998) Overview of the epidemiology of immunodeficiency-associated cancers. J Natl Cancer Inst Monogr 23: 1-6.
4. Birek, C., and Ficarra, G. (2006) The diagnosis and management of oral herpes simplex infection. Curr Infect Dis Rep 8: 181-188.
5. Brenner, S., Prosch, S., Schenke-Layland, K., Riese, U., Gausmann, U., and Platzer, C. (2003) cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J Biol Chem 278: 5597-5604.
6. Casper, C., Wald, A., Pauk, J., Tabet, S.R., Corey, L., and Celum, C.L. (2002) Correlates of prevalent and incident Kaposi's sarcoma-associated herpesvirus infection in men who have sex with men. J Infect Dis 185: 990-993.
7. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M., and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266: 1865-1869.
8. Chang, P.J., Shedd, D., and Miller, G. (2005) Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA. J Virol 79: 8750-8763.
9. Chen, H., Teng, L., Li, J.N., Park, R., Mold, D.E., Gnabre, J., et al. (1998) Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. J Med Chem 41: 3001-3007.
10. Chen, T., and Hudnall, S.D. (2006) Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol 19: 726-737.
11. Cocchi, F., Fusco, D., Menotti, L., Gianni, T., Eisenberg, R.J., Cohen, G.H., and Campadelli-Fiume, G. (2004) The soluble ectodomain of herpes simplex virus gD contains a membrane-proximal pro-fusion domain and suffices to mediate virus entry. Proc Natl Acad Sci USA 101: 7445-7450.
12. Decker, L.L., Shankar, P., Khan, G., Freeman, R.B., Dezube, B.J., Lieberman, J., and Thorley-Lawson, D.A. (1996) The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients. J Exp Med 184: 283-288.
13. Dourmishev, L.A., Dourmishev, A.L., Palmeri, D., Schwartz, R.A., and Lukac, D.M. (2003) Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67: 175-212. table of contents.
14. Drexler, H.G., Meyer, C., Gaidano, G., and Carbone, A. (1999) Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 13: 634-640.
15. Fiorelli, V., Gendelman, R., Samaniego, F., Markham, P.D., and Ensoli, B. (1995) Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 95: 1723-1734.
16. Foreman, K.E., Friborg, J., Jr, Kong, W.P., Woffendin, C., Polverini, P.J., Nickoloff, B.J., and Nabel, G.J. (1997) Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med 336: 163-171.
17. Halford, W.P., Gebhardt, B.M., and Carr, D.J. (1996) Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J Immunol 157: 3542-3549.
18. Harel, L., Smetana, Z., Prais, D., Book, M., Alkin, M., Supaev, E., et al. (2004) Presence of viremia in patients with primary herpetic gingivostomatitis. Clin Infect Dis 39: 636-640.
19. Husain, S.R., Kreitman, R.J., Pastan, I., and Puri, R.K. (1999) Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model. Nat Med 5: 817-822.
20. Jones, K.D., Aoki, Y., Chang, Y., Moore, P.S., Yarchoan, R., and Tosato, G. (1999) Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94: 2871-2879.
21. Key, N.S., Vercellotti, G.M., Winkelmann, J.C., Moldow, C.F., Goodman, J.L., Esmon, N.L., et al. (1990) Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 87: 7095-7099.
22. Krzyzowska, M., Schollenberger, A., and Niemialtowski, M.G. (2000) How human immunodeficiency viruses and herpesviruses affect apoptosis. Acta Virol 44: 203-210.
23. Kumar, N., McLean, K., Inoue, N., Moles, D.R., Scully, C., Porter, S.R., and Teo, C.G. (2007) Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma. J Med Virol 79: 52-59.
24. Lamontagne, L., and Jolicoeur, P. (1994) Herpes simplex virus type 1 pathogenicity in mice expressed by lytic infection in pre-B and B cells. Clin Immunol Immunopathol 73: 38-44.
25. Lin, S.S., Chou, M.Y., Ho, C.C., Kao, C.T., Tsai, C.H., Wang, L., and Yang, C.C. (2005) Study of the viral infections and cytokines associated with recurrent aphthous ulceration. Microbes Infect 7: 635-644.
26. Li-Weber, M., Salgame, P., Hu, C., Davydov, I.V., Laur, O., Klevenz, S., and Krammer, P.H. (1998) Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter. J Immunol 161: 1380-1389.
27. Lu, C., Gordon, G.M., Chandran, B., Nickoloff, B.J., and Foreman, K.E. (2002) Human herpesvirus 8 reactivation and human immunodeficiency virus type 1 gp120. Arch Pathol Lab Med 126: 941-946.
28. Lu, C., Zeng, Y., Huang, Z., Huang, L., Qian, C., Tang, G., and Qin, D. (2005) Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus. Am J Pathol 166: 173-183.
29. Lukac, D.M., Renne, R., Kirshner, J.R., and Ganem, D. (1998) Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252: 304-312.
30. McAllister, S.C., Hansen, S.G., Messaoudi, I., Nikolich-Zugich, J., and Moses, A.V. (2005) Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase. J Virol 79: 2626-2630.
31. Mann, S.L., Meyers, J.D., Holmes, K.L., and Corey, L. (1984) Prevalence and incidence of herpesvirus infections among homosexually active men. J Infect Dis 149: 1026-1027.
32. Masood, R., Zhang, Y., Bond, M.W., Scadden, D.T., Moudgil, T., Law, R.E., et al. (1995) Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood 85: 3423-3430.
33. Mendez, J.C., Procop, G.W., Espy, M.J., Smith, T.F., McGregor, C.G., and Paya, C.V. (1999) Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation. Transplantation 67: 1200-1201.
34. Mercader, M., Taddeo, B., Panella, J.R., Chandran, B., Nickoloff, B.J., and Foreman, K.E. (2000) Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 156: 1961-1971.
35. Miles, S.A., Testa, M., Huang, J., Wade, M., Carden, J., and Scadden, D.T. (2002) Lack of antitumor activity and intolerance of interleukin-4 in patients with advanced HIV disease and Kaposi's sarcoma. J Interferon Cytokine Res 22: 1143-1148.
36. Miller, C.S., Avdiushko, S.A., Kryscio, R.J., Danaher, R.J., and Jacob, R.J. (2005) Effect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatment. J Clin Microbiol 43: 2173-2180.
37. Miller, C.S., Berger, J.R., Mootoor, Y., Avdiushko, S.A., Zhu, H., and Kryscio, R.J. (2006) High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J Clin Microbiol 44: 2409-2415.
38. Milligan, S., Robinson, M., O'Donnell, E., and Blackbourn, D.J. (2004) Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells. J Virol 78: 2591-2596.
39. Monini, P., Colombini, S., Sturzl, M., Goletti, D., Cafaro, A., Sgadari, C., et al. (1999) Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93: 4044-4058.
40. Oksenhendler, E., Carcelain, G., Aoki, Y., Boulanger, E., Maillard, A., Clauvel, J.P., and Agbalika, F. (2000) High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96: 2069-2073.
41. Puri, R.K. (2000) IL-4 receptor-directed cytotoxin for therapy of AIDS-associated KS tumors. Drug News Perspect 13: 395-402.
42. Russo, J.J., Bohenzky, R.A., Chien, M.C., Chen, J., Yan, M., Maddalena, D., et al. (1996) Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93: 14862-14867.
43. Schulz, T.F., and Moore, P.S. (1999) Kaposi's sarcoma-associated herpesvirus: A new human tumor virus, but how? Trends Microbiol 7: 196-200.
44. Seaman, W.T., Ye, D., Wang, R.X., Hale, E.E., Weisse, M., and Quinlivan, E.B. (1999) Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 263: 436-449.
45. Sirianni, M.C., Vincenzi, L., Fiorelli, V., Topino, S., Scala, E., Uccini, S., et al. (1998) Gamma-interferon production in peripheral blood mononuclear cells and tumor infiltrating lymphocytes from Kaposi's sarcoma patients: Correlation with the presence of human herpesvirus-8 in peripheral blood mononuclear cells and lesional macrophages. Blood 91: 968-976.
46. Staskus, K.A., Zhong, W., Gebhard, K., Herndier, B., Wang, H., Renne, R., et al. (1997) Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol 71: 715-719.
47. Sturzl, M., Blasig, C., Schreier, A., Neipel, F., Hohenadl, C., Cornali, E., et al. (1997) Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer 72: 68-71.
48. Sun, R., Lin, S.F., Gradoville, L., Yuan, Y., Zhu, F., and Miller, G. (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci USA 95: 10866-10871.
49. Sun, R., Lin, S.F., Staskus, K., Gradoville, L., Grogan, E., Haase, A., and Miller, G. (1999) Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 73: 2232-2242.
50. Varthakavi, V., Browning, P.J., and Spearman, P. (1999) Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J Virol 73: 10329-10338.
51. Varthakavi, V., Smith, R.M., Deng, H., Sun, R., and Spearman, P. (2002) Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology 297: 270-280.
52. Vieira, J., O'Hearn, P., Kimball, L., Chandran, B., and Corey, L. (2001) Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus. J Virol 75: 1378-1386.
53. Zeng, Y., Zhang, X., Huang, Z., Cheng, L., Yao, S., Qin, D., et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: Role of JAK/STAT signaling. J Virol 81: 2401-2417.